デフォルト表紙
市場調査レポート
商品コード
1593509

血液透析・腹膜透析の市場規模・シェア・成長分析 (種類別、製品別、最終用途別、地域別):産業予測 (2024~2031年)

Hemodialysis and Peritoneal Dialysis Market Size, Share, Growth Analysis, By Type (Hemodialysis, Peritoneal Dialysis), By Product (Device, Consumables), By End Use (Home-based, Hospital-based), By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 188 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
血液透析・腹膜透析の市場規模・シェア・成長分析 (種類別、製品別、最終用途別、地域別):産業予測 (2024~2031年)
出版日: 2024年11月10日
発行: SkyQuest
ページ情報: 英文 188 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の血液透析・腹膜透析の市場規模は、2022年に811億1,000万米ドルとなり、2023年の863億8,000万米ドルから2031年には1,429億7,000万米ドルに拡大し、予測期間 (2024~2031年) に6.5%のCAGRで成長する見通しです。

世界の血液透析・腹膜透析市場は、臓器提供者の不足、急性腎障害の有病率の上昇、臓器移植の関連リスクなどを背景に、大きな成長を遂げています。また、大手企業の技術進歩やイノベーションが、新製品やサービスの開発に拍車をかけています。慢性腎臓病 (CKD) は、しばしば末期腎不全 (ESRD) につながりますが、この市場の主要な需要促進要因であり、腎機能の低下は糖尿病や高血圧などの病態と関連しています。特に高齢化・肥満・生活習慣の乱れによる糖尿病の罹患率の増加が、糖尿病性腎症や腎障害の一因となっており、世界的に透析治療の需要をさらに加速させています。

目次

イントロダクション

  • 分析目的
  • 定義
  • 市場範囲

分析手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場の概要と見通し
  • 需給動向の分析
  • セグメント別の機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 主な成功要因
  • 競合の程度
  • 主な投資機会
  • 市場のエコシステム
  • 規制情勢
  • バリューチェーン分析
  • サプライチェーン分析
  • 技術分析
  • 特許分析
  • 価格分析
  • 貿易分析
  • 顧客と購買基準の分析

血液透析・腹膜透析市場:種類別

  • 市場概要
  • 血液透析
    • 従来型
    • 短期透析
    • 夜間血液透析
  • 腹膜透析
    • 持続携帯式腹膜透析 (CAPD)
    • 自動腹膜透析 (APD)

血液透析・腹膜透析市場:製品別

  • 市場概要
  • 装置
    • 機械
    • 透析装置
    • 水処理システム
    • その他
  • 消耗品
    • 血液ライン
    • 濃縮物
    • カテーテル
    • その他
  • サービス

血液透析・腹膜透析市場:最終用途別

  • 市場概要
  • 在宅ベース
  • 病院ベース

血液透析・腹膜透析市場:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ
  • 中東・アフリカ (MEA)
    • 湾岸協力会議 (GCC) 諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング (2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア (2023年)

主要企業プロファイル

  • Fresenius Medical Care AG (ドイツ)
  • Baxter (米国)
  • Davita Inc. (米国)
  • Nikkiso Co., Ltd. (日本)
  • B. Braun SE (ドイツ)
  • Medtronic (米国)
  • Asahi Kasei Corporation (日本)
  • Terumo Corporation (日本)
  • Toray Medical Co., Ltd. (日本)
  • Nipro Corporation (日本)
  • Diaverum AB (スウェーデン)
  • Dialife SA (スイス)
  • Isopure Corp. (米国)
  • Rockwell Medical, Inc. (米国)
  • Becton, Dickinson and Company (米国)
  • JMS Co. Ltd. (日本)
  • Allmed Medical Products Co., Ltd. (中国)
  • Atlantic Biomedical (米国)
  • AngioDynamics (米国)
  • Amecath (Egypt)
  • Cook (米国)
  • Medical Components Inc. (米国)
  • Polymedicure (インド)
  • Xylem (米国)
  • Outset Medical, Inc. (米国)
目次
Product Code: SQMIG35D2277

Global Hemodialysis and Peritoneal Dialysis Market size was valued at USD 81.11 billion in 2022 and is poised to grow from USD 86.38 billion in 2023 to USD 142.97 billion by 2031, growing at a CAGR of 6.5% in the forecast period (2024-2031).

The global hemodialysis and peritoneal dialysis market is experiencing significant growth, driven by a shortage of organ donors, the rising prevalence of acute kidney injury, and the associated risks of organ transplants. Additionally, technological advancements and innovations from leading market players are fueling the development of new products and services. Chronic kidney disease (CKD), often leading to End-Stage Renal Disease (ESRD), is a major driver of this demand, with kidney function decline linked to conditions like diabetes and hypertension. The growing incidence of diabetes, particularly due to aging, obesity, and poor lifestyle choices, is contributing to diabetic nephropathy and renal damage, further accelerating the demand for dialysis treatments globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemodialysis and Peritoneal Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemodialysis and Peritoneal Dialysis Market Segmental Analysis

Global Hemodialysis and Peritoneal Dialysis Market is segmented on the type, product, end use, and region. By type, Market is segmented into Hemodialysis, and Peritoneal Dialysis. By product, Market is segmented into Device, Consumables, and Service. By end use, Market is segmented into Home-based, and Hospital-based. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Hemodialysis and Peritoneal Dialysis Market

The rising awareness campaigns surrounding kidney diseases and the availability of treatment options are driving early diagnosis and intervention, thereby expanding the patient base for dialysis therapies. Global initiatives such as World Kidney Day have played a key role in raising awareness about kidney health, encouraging regular screenings. This focus on early detection enables timely interventions, which are crucial for effective treatment. As more people undergo screenings and seek care at earlier stages, the demand for dialysis treatments, including hemodialysis and peritoneal dialysis, is growing. These efforts are contributing significantly to the market's expansion by addressing the increasing need for dialysis solutions worldwide.

Restraints in the Global Hemodialysis and Peritoneal Dialysis Market

The high costs associated with hemodialysis treatment, including equipment, consumables, and facility fees, present a significant challenge to the growth of the global Hemodialysis and Peritoneal Dialysis market. In low- and middle-income countries, the financial burden of accessing proper treatment becomes even more pronounced due to the high expense of necessary equipment. Additionally, reimbursement issues and limited insurance coverage exacerbate these challenges, making it difficult for many patients to afford consistent care. These financial constraints limit the accessibility of treatment options and hinder the overall expansion of the market.

Market Trends of the Global Hemodialysis and Peritoneal Dialysis Market

The global Hemodialysis and Peritoneal Dialysis market is experiencing significant growth driven by the rising prevalence of chronic kidney disease (CKD), improved healthcare infrastructure, and expanded access to renal replacement therapies. Emerging markets present substantial growth opportunities, as these regions see a surge in demand for affordable, localized dialysis solutions. Companies can leverage this growth potential by entering developing economies with cost-effective offerings tailored to meet the specific needs of these markets. This trend highlights the vast potential for expansion, as the demand for dialysis treatments continues to rise globally.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Regulatory Landscape
  • Value Chain Analysis
  • Supply Chain Analysis
  • Technology Analysis
  • Patent Analysis
  • Pricing Analysis
  • Trade Analysis
  • Customer & Buying Criteria Analysis

Hemodialysis And Peritoneal Dialysis Market, By Type

  • Market Overview
  • Hemodialysis
    • Conventional
    • Short Daily Hemodialysis
    • Nocturnal Hemodialysis
  • Peritoneal Dialysis
    • Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • Automated Peritoneal Dialysis (APD)

Hemodialysis And Peritoneal Dialysis Market, By Product

  • Market Overview
  • Device
    • Machine
    • Dialyzers
    • Water Treatment System
    • Others
  • Consumables
    • Bloodlines
    • Concentrates
    • Catheters
    • Others
  • Service

Hemodialysis And Peritoneal Dialysis Market, By End Use

  • Market Overview
  • Home-based
  • Hospital-based

Hemodialysis And Peritoneal Dialysis Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Fresenius Medical Care AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Davita Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nikkiso Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun SE (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Asahi Kasei Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Toray Medical Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diaverum AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dialife SA (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Isopure Corp. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rockwell Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JMS Co. Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allmed Medical Products Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Atlantic Biomedical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amecath (Egypt)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medical Components Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Polymedicure (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Xylem (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Outset Medical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments